A NOVEL EXPLORING APPROACH OF CANCER CHEMOTHERAPY BY MULTIPLE EMULSION SYSTEM
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 2
Abstract
Cancer is a disease characterized by uncontrolled multiplication and spread of abnormal forms of the body's own cells, leading cause of death worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008. Most common cancers are Lung, Liver, Colon, Rectum, Breast Ovarian & Prostate cause the most deaths each year. Lung cancer is the most frequent lethal cancer, 1.4 million cases per year by use of long-term exposure to tobacco smoke. Chemotherapy is the treatment of cancer with an antineoplastic drug or with a combination of such drugs into a standardized treatment regimen. Attempts to treat tumors with the single agents are often disappointing. A single drug usually kills the most sensitive population of cells in a tumor, leaving a resistant fraction unharmes and still dividing. Therefore, each time the same agent is readministered, the tumor becomes more resistant and the treatment less efficacious. The parenteral Sustained release dosage forms are most effective and common form of delivery for active drug substance & designed to achieve a prolonged therapeutic effect by continuously releasing medication over extended period of time after administration of single dose. For this reason whatever drug delivery technology that can reduce the total number of injection throughout the drug therapy period will be truly advantageous not only in term of compliance but also for potential to improve the quality of the therapy. Such reduction in the frequency of drug is achieved, by the use of specific formulation technologies that guarantee that the release of the active drug substance happens in a slow and predictable manner. Multiple emulsions of w/o/w and o/w/o type are becoming popular since an additional reservoir is presented to the drug for partitioning which can effectively retard it release rate.
Authors and Affiliations
Shivjee Kumar , Stuti Singh , Usmeet Kaur , Nisha Raina , Vandita Kakkar
Keywords
Related Articles
- EP ID EP92558
- DOI -
- Views 97
- Downloads 0
A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
Trasdermal drug delivery system is topically administered medicaments in the form of patches that deliver drugs for systemic effects at a predetermined and controlled rate. Today about 74% of drugs are taken orally and a...
RECENT ADVANCEMENT OF LIPID DRUG CONJUGATE AS NANOPARTICULATE DRUG DELIVERY SYSTEM
Nanotechnology by manipulation of characteristics of materials such as polymers and fabrication of nanostructures is able to provide superior drug delivery systems for better management and treatment of diseases. The nan...
ANIMAL MODELS FOR HUNTINGTON’S DISEASES: A REVIEW
Huntington's disease (HD) is an inherited autosomal, progressive neurodegenerative disorder associated with involuntary abnormal movements (chorea), cognitive impairments and psychiatric disturbances. HD is caused by an...
MENTAL HEALTH CHALLENGES AND POSSIBLE SOLUTIONS WITH SPECIAL REFERENCE TO ANXIETY
Mental disorders are universal and very common. No country can postpone service development until the finalization of national level epidemiological surveys. It should be noted also that such surveys are very costly and...
SYNTHESIS AND ANTHELMINTIC ACTIVITY OF 3-(2-HYDRAZINO BENZOTHIAZOLES)-SUBSTITUTED INDOLE-2-ONE
Benzothiazoles and Isatins have emerged as structurally novel anthelmintics. Therefore various 3-(2-hydrazino benzothiazoles)-substituted Indole-2-one, were synthesized by condensation of various 2-hydrazino benzothiazol...